Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

GENEWIZ, BeiGene partner for biomarkers
September 2013
SHARING OPTIONS:

SOUTH PLAINFIELD, N.J.A collaboration was recently announced between GENEWIZ Inc. and BeiGene to accelerate cancer biomarker discovery. BeiGene brings with it more than 100 patient-derived primary tumor models in-house in their portfolio of early-stage oncology therapies. By using GENEWIZ's OncoGxOne Discovery cancer panels, which provide comprehensive genomic analysis, BeiGene will be able to identify genetic variations in cancers prevalent in China and the Asia-Pacific region.
 
"Our collaboration with GENEWIZ and application of the OncoGxOne cancer panels will enable characterization of primary tumor models at the genetic level, with a focus on aberrations in cancer-related genes," Dr. Lai Wang, head of discovery biomarkers at BeiGene, said in a press release, adding that the collaboration "will strongly support our translational research and biomarker discovery."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.